| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 2e-05 | 1 |